Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Virology|November 27, 2007
Human immunodeficiency virus 1 (HIV-1) virion infectivity factor (Vif) is part of reverse transcription complexes and acts as an accessory factor for reverse transcriptionJillian M Carr, Carl Coolen, Adam J Davis, et al.Cellular Signalling|April 21, 2010
Sphingosine and FTY720 directly bind pro-survival 14-3-3 proteins to regulate their functionJoanna M Woodcock, Yuefang Ma, Carl Coolen, et al.Oncotarget|May 15, 2015
Destabilisation of dimeric 14-3-3 proteins as a novel approach to anti-cancer therapeuticsJoanna M Woodcock, Carl Coolen, Katy L Goodwin, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|October 9, 2025
Polymeric-lipid nanoparticles that leverage cationic helper lipids and the protein corona for lung-targeted delivery of a novel anti-cancer drugSanthni Subramaniam, Leigh Donnellan, Anthony Wignall, et al.The Journal of Biological Chemistry|November 8, 2017
Role of salt bridges in the dimer interface of 14-3-3ζ in dimer dynamics, N-terminal α-helical order, and molecular chaperone activityJoanna M Woodcock, Katy L Goodwin, Jarrod J Sandow, et al.The Journal of Allergy and Clinical Immunology|May 1, 2023
IgE receptor of mast cells signals mediator release and inflammation via adaptor protein 14-3-3ζKwok Ho Yip, Jessica Chao, Carl Coolen, et al.Oncotarget|March 20, 2015
A selective ATP-competitive sphingosine kinase inhibitor demonstrates anti-cancer propertiesMelissa R Pitman, Jason A Powell, Carl Coolen, et al.Pageof 1